MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
HealthStream Total Assets 2011-2026 | HSTM
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets HealthStream
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 511 M | 500 M | 498 M | 487 M | 500 M | 490 M | 442 M | 411 M | 396 M | 380 M | 257 M | 213 M | 175 M | 154 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 511 M | 154 M | 387 M |
Quarterly Total Assets HealthStream
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 500 M | 500 M | 524 M | 511 M | 503 M | 500 M | 512 M | 500 M | 498 M | 493 M | 503 M | 498 M | 481 M | - | 484 M | 487 M | 495 M | 496 M | 502 M | 500 M | 500 M | 500 M | 500 M | 490 M | 490 M | 490 M | 490 M | 442 M | 442 M | 442 M | 442 M | 411 M | 411 M | 411 M | 411 M | 396 M | 396 M | 396 M | 396 M | 380 M | 380 M | 380 M | 380 M | 257 M | 257 M | 257 M | 257 M | 213 M | 213 M | 213 M | 213 M | 175 M | 175 M | 175 M | 175 M | 154 M | 154 M | 154 M | 154 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 524 M | 154 M | 391 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B |  USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 13.1 | -1.95 % | $ 224 M | USA |
 |
Health Catalyst
HCAT
|
859 M | $ 2.45 | - | $ 147 M | USA |
 |
Phreesia
PHR
|
370 M | $ 17.35 | 2.66 % | $ 947 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 4.2 | 0.72 % | $ 394 M | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
So-Young International
SY
|
2.74 B | $ 2.64 | 1.15 % | $ 210 M |  China |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
965 M | $ 20.26 | 5.03 % | $ 2.37 B | USA |
 |
HealthEquity
HQY
|
3.16 B | $ 95.53 | -3.03 % | $ 8.17 B | USA |
 |
American Well Corporation
AMWL
|
436 M | $ 5.15 | -1.44 % | $ 77.2 M | USA |
 |
Premier
PINC
|
3.1 B | $ 28.26 | - | $ 2.33 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
71.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.82 | 1.08 % | $ 1.09 B | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 50.96 | 0.74 % | $ 2.35 B | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
Veeva Systems
VEEV
|
5.91 B | $ 242.97 | 0.75 % | $ 39 B | USA |
 |
Progyny
PGNY
|
607 M | $ 27.75 | 1.15 % | $ 2.38 B | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 0.54 | 2.14 % | $ 2.81 M | China |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
Schrödinger
SDGR
|
823 M | $ 18.61 | - | $ 1.35 B | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
3.52 B | $ 7.45 | -2.17 % | $ 1.27 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.2 | 0.26 % | $ 292 K | USA |